Amphastar Pharmaceuticals (AMPH) vs Latigo Biotherapeutics (LTGO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Amphastar Pharmaceuticals is the larger company by market cap ($1.09 billion vs $1.03 billion), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AMPH | LTGO |
|---|---|---|
| Share price | $25.54 | $15.52 |
| Market cap | $1.09B | $1.03B |
| 1-day change | -1.43% | -4.55% |
| YTD return | -4.63% | — |
| 1-year return | -1.12% | — |
| 5-year return | +33.65% | — |
| P/E ratio (TTM) | 15.11 | — |
| Forward P/E | 8.03 | — |
| EPS (TTM) | $1.69 | $-2.52 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $29.52 | $25.93 |
| 52-week low | $16.65 | $15.27 |
| Distance from 52-week high | -13.48% | -40.15% |
| Average volume | 467.79K | 397.83K |
| Shares outstanding | 42.54M | 66.30M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
AMPH vs LTGO FAQ
Which is bigger, Amphastar Pharmaceuticals or Latigo Biotherapeutics?
Amphastar Pharmaceuticals (AMPH) is larger, with a market capitalization of $1.09B compared with $1.03B for Latigo Biotherapeutics (LTGO).
Are Amphastar Pharmaceuticals and Latigo Biotherapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.